nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment and stratification of cardiovascular disease risk in people diagnosed with breast cancer: A scoping review
|
Jeon, Mi Hye |
|
|
135 |
C |
p. |
artikel |
2 |
Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review
|
Galli, Edoardogregorio |
|
|
135 |
C |
p. |
artikel |
3 |
Current controversies in the use of Oncotype DX in early breast cancer
|
Berton Giachetti, Pier Paolo M. |
|
|
135 |
C |
p. |
artikel |
4 |
Editorial Board
|
|
|
|
135 |
C |
p. |
artikel |
5 |
First-line treatment of locally advanced cervical carcinoma: An updated systematic review and Bayesian network meta-analysis
|
Petrelli, Fausto |
|
|
135 |
C |
p. |
artikel |
6 |
First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?
|
Nguyen Van Long, Flora |
|
|
135 |
C |
p. |
artikel |
7 |
Functioning neuroendocrine tumors (NET): Minimum requirements for a NET specialist
|
Spada, F. |
|
|
135 |
C |
p. |
artikel |
8 |
Identification of the PROMs used to assess ICI toxicities and HRQoL in patients receiving immune checkpoint inhibitor treatment in cancer care and their suitability: A systematic review
|
Georgopoulou, Sofia |
|
|
135 |
C |
p. |
artikel |
9 |
Impact of loss of HER2 positivity following neoadjuvant therapy in HER2-positive breast cancer patients on long-term prognosis: A systematic review and meta-analysis
|
Nakatani, Shunsuke |
|
|
135 |
C |
p. |
artikel |
10 |
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
|
Géraud, Arthur |
|
|
135 |
C |
p. |
artikel |
11 |
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer
|
Sahin, Taha Koray |
|
|
135 |
C |
p. |
artikel |
12 |
The evolving landscape of stage III unresectable non-small cell lung cancer “between lights and shadows”
|
Delcuratolo, Marco Donatello |
|
|
135 |
C |
p. |
artikel |
13 |
Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck
|
Szturz, Petr |
|
|
135 |
C |
p. |
artikel |